Understanding bowel cancer risk in inflammatory bowel disease
Part of Digestive system clinical trials.
This study follows patients with inflammatory bowel disease (Crohn's or ulcerative colitis) to better understand abnormal growths in the colon (dysplasia) and their risk of turning into cancer. It aims to improve how we predict and prevent cancer in IBD patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with Crohn's disease or ulcerative colitis.
- You have had IBD for at least 8 years (or at least 1 year if you also have primary sclerosing cholangitis).
- For ulcerative colitis: your disease affects the left side or the entire colon (not just the rectum).
- For Crohn's disease: your disease involves at least half of your colon or both your colon and small intestine.
- You are scheduled for a colonoscopy to check for dysplasia and agree to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This study looks at healthy family members of people with Crohn's disease or ulcerative colitis to find early signs of these conditions before symptoms appear. It may help doctors predict and prevent inflammatory bowel disease.
This study looks at how microbes in your gut might influence scarring (fibrosis) and immune responses in the intestines of people with Crohn's disease. It compares tissue samples from Crohn's patients to those from people without inflammatory bowel disease (like diverticulitis).
This trial looks at whether taking random biopsies during a routine colonoscopy is helpful for people with inflammatory bowel disease (IBD) who are at risk for colon cancer. It aims to understand if random biopsies can detect early signs of cancer or pre-cancer.
This study follows patients with Crohn's disease or ulcerative colitis to see how their intestine heals after surgery. It looks for signs that can predict whether inflammation will return or complications will happen.
This study follows people who have a parent, sibling, or child with Crohn's disease or ulcerative colitis to help understand why some family members develop the condition. If you are 14 or older and do not already have IBD, you may be able to join.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.